Literature DB >> 15487455

Proliferating pilar tumors: a clinicopathologic study of 76 cases with a proposal for definition of benign and malignant variants.

Jay Ye1, Oscar Nappi, Paul E Swanson, James W Patterson, Mark R Wick.   

Abstract

We studied proliferating pilar tumors (PPTs) to establish histologic criteria that could predict behavior. We reviewed all cases in our consultation files (1989-2000) and evaluated 76 cases with meaningful follow-up information. Histologic examination involved attention to tumor silhouette, degree of nuclear atypia, mitotic activity, necrosis, and perineurial or angiolymphatic invasion. Tumors were stratified as follows: group 1 PPTs, circumscribed silhouettes with "pushing " margins, modest nuclear atypia, and an absence of pathologic mitoses, necrosis, and invasion of nerves or vessels; group 2 PPTs, similar to group 1 but manifested irregular, locally invasive silhouettes with involvement of the deep dermis and subcutis; group 3, invasive growth patterns, marked nuclear atypia, pathologic mitotic forms, and geographic necrosis, with or without involvement of nerves or vascular structures. Recurrence occurred in none of 48 group 1 PPTs; 3 (15%) of 20 group 2 PPTs had local regrowth; 4 (50%) of 8 of group 3 PPTs recurred and/or metastasized to regional lymph nodes. The differences between groups 1 and 3 and between 2 and 3 were statistically significant (P = .0002, P < .05, respectively). It seems justifiable to regard group 1 PPTs as benign, group 2 as having potential for locally aggressive growth, and group 3 also as having metastatic potential. The latter 2 categories might be equated with low and high grades of malignancy among PPTs of the skin.

Entities:  

Mesh:

Year:  2004        PMID: 15487455     DOI: 10.1309/21DK-LY2R-94H1-92NK

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  30 in total

1.  [Gigantic exophytically growing tumor of the occipital scalp : A complex diagnostic and reconstructive challenge].

Authors:  T Jaehn; J Kaiser; M Billner; A Kaiser; B Reichert
Journal:  Chirurg       Date:  2017-10       Impact factor: 0.955

2.  An Unusual Presentation of a Breast Lump.

Authors:  Narendra Pai; Amol Amonkar; Rajesh Ballal
Journal:  Indian J Surg       Date:  2016-08-19       Impact factor: 0.656

3.  Low grade malignant proliferating pilar tumor arising from breast skin simulating squamous cell carcinoma, a case report.

Authors:  Majid Akrami; Abdolrasoul Talei; Bahman Nazemzadegan; Ahmad Abdollahi; Fatemeh Sari Aslani; Akbar Safaei; Sedigheh Tahmasebi
Journal:  Indian J Surg Oncol       Date:  2013-11-13

4.  Malignant proliferating trichilemmal tumor in young male.

Authors:  Prasad K Shetty; Srikanth Jagirdar; K Balaiah; Deepak Shetty
Journal:  Indian J Surg Oncol       Date:  2013-08-21

5.  Trichilemmal Carcinoma from Proliferating Trichilemmal Cyst on the Posterior Neck.

Authors:  Ui Geon Kim; Dong Bee Kook; Tae Hun Kim; Chung Hun Kim
Journal:  Arch Craniofac Surg       Date:  2017-03-25

6.  Metastatic trichilemmal carcinoma in a patient with breast cancer.

Authors:  Chrysis Sofianos; Nkhensani Y Chauke; Alexandra Grubnik
Journal:  BMJ Case Rep       Date:  2016-11-21

7.  Malignant Proliferating Trichilemmal Tumour of the Scalp with Intra-Cranial Extension and Lung Metastasis-a Case Report.

Authors:  Lancelot Lobo; Amol Dilip Amonkar; V V S M Kumar Dontamsetty
Journal:  Indian J Surg       Date:  2016-01-15       Impact factor: 0.656

8.  Extensive and ulcerated malignant proliferating trichilemmal (pilar) tumour, arising from multiple, large, degenerated trichilemmal (pilar) cysts.

Authors:  Bruno Morgado; Patrick Agostini; António Rivero; Nuno Silva
Journal:  BMJ Case Rep       Date:  2016-02-08

9.  Differential diagnosis of soft scalp lumps.

Authors:  Lawrence K Leung
Journal:  BMJ Case Rep       Date:  2011-11-15

10.  Proliferating trichilemmal tumor of the nose.

Authors:  Aristóteles Rosmaninho; Mónica Caetano; Ana Oliveira; Teresa Pinto de Almeida; Manuela Selores; Rosário Alves
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.